Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
about
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@en
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@nl
type
label
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@en
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@nl
prefLabel
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@en
Allogeneic Mesenchymal Stem Ce ...... ebo-Controlled Clinical Trial.
@nl
P2093
P2860
P356
P1476
Allogeneic Mesenchymal Stem Ce ...... cebo-Controlled Clinical Trial
@en
P2093
Adam Mendizabal
Aisha Khan
Alan W Heldman
Ana Marie Landin
Anthony A Oliva
Audrey Medina
Bradley J Goldstein
Bryon A Tompkins
Cindy Delgado
Courtney Premer
P2860
P304
P356
10.1093/GERONA/GLX137
P407
P577
2017-10-01T00:00:00Z